Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interleukin-6 in myeloma/plasmacytoma.

International review of experimental pathology - 1 Jan 1993

Suematsu S, Matsusaka T, Matsuda T, Hirano T, Kishimoto T

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genes, Synthetic
Share to H-2 Antigens
Share to Histocompatibility Antigen H-2D
Share to Immunoglobulin mu-Chains

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Lymphoid Tissue

Share to Mice, Inbred NZB

Share to Plasma Cells

Share to Plasmacytoma

Source

Identifiers

PMID: 8454420

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interleukin-6 in myeloma/plasmacytoma.PMID 8454420Read ↗

New insights in the clinical biology of multiple myeloma.Semantic proximity Read ↗

IL-6 polymorphism, anti-IL-6 therapy and animal models of multiple myeloma.Semantic proximity Read ↗

[Recent biological and therapeutic advances in multiple myeloma].Semantic proximity Read ↗

Role of interleukin 6 in the growth of myeloma-derived cell lines.Semantic proximity Read ↗

Pathogenetic relation between monoclonal gammopathies of undetermined significance and multiple myeloma.Semantic proximity Read ↗

Interleukin-6-related genotypes, body mass index, and risk of multiple myeloma and plasmacytoma.Semantic proximity Read ↗

Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation.Semantic proximity Read ↗

Mcl‐1 and Bcl‐x<sub>L </sub> are co‐regulated by IL‐6 in human myeloma cellsSemantic proximity Read ↗

The bone marrow stromal microenvironment influences myeloma therapeutic response in vitro.Semantic proximity Read ↗

Interleukin-6 gene-174 G/C promoter polymorphism and its association with clinical profile of patients with multiple myeloma.Semantic proximity Read ↗

IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factorsSemantic proximity Read ↗

Autocrine interleukin-6 production and highly malignant multiple myeloma: relation with resistance to drug-induced apoptosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.